OKX Ventures Invests in Nytro Lab's Castile; Beta Test for AAA Web 3 RPG Launched on September 10
September 10, 2024 23:15 ET
|
OKX
SINGAPORE, Sept. 11, 2024 (GLOBE NEWSWIRE) -- OKX Ventures, the investment arm of leading Web3 technology company OKX, has issued updates for September 11, 2024. OKX Ventures...
Power Tools Market Size & Share to Surpass USD 51.02 Billion by 2033, at a CAGR 2.88% - The Brainy Insights
September 10, 2024 23:00 ET
|
The Brainy Insights
Newark, Sept. 10, 2024 (GLOBE NEWSWIRE) -- The Brainy Insights estimates that the USD 38.42 billion in 2023 global power tools market will reach USD 51.02 billion in 2033. Power tools are essential...
OKX is TOKEN2049 Singapore Title Sponsor for Third Straight Year
September 10, 2024 23:00 ET
|
OKX
SINGAPORE, Sept. 11, 2024 (GLOBE NEWSWIRE) -- OKX, a global Web3 technology company, today announced that it is the Title Sponsor of TOKEN2049 Singapore, Asia's premier Web3 and crypto conference,...
WEBTOON SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against WEBTOON Entertainment Inc. - WBTN
September 10, 2024 22:54 ET
|
Kahn Swick & Foti, LLC
NEW ORLEANS, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until...
SUPER MICRO COMPUTER SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Super Micro Computer, Inc. - SMCI
September 10, 2024 22:54 ET
|
Kahn Swick & Foti, LLC
NEW ORLEANS, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until...
AMERICAN AIRLINES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against American Airlines Group Inc. - AAL
September 10, 2024 22:53 ET
|
Kahn Swick & Foti, LLC
NEW ORLEANS, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until...
METHODE ELECTRONICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Methode Electronics, Inc. - MEI
September 10, 2024 22:52 ET
|
Kahn Swick & Foti, LLC
NEW ORLEANS, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until...
STELLANTIS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Stellantis N.V. - STLA
September 10, 2024 22:51 ET
|
Kahn Swick & Foti, LLC
NEW ORLEANS, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until...
ORTHOFIX MEDICAL SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Orthofix Medical, Inc. - OFIX
September 10, 2024 22:51 ET
|
Kahn Swick & Foti, LLC
NEW ORLEANS, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until...
Terns Announces Pricing of Upsized $150.15 Million Public Offering
September 10, 2024 22:50 ET
|
Terns Pharmaceuticals, Inc.
FOSTER CITY, Calif., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of...